ZA773304B - B-aryl-2-aminoalkoxystyrols as drugs with an antiarrhythmic activity - Google Patents
B-aryl-2-aminoalkoxystyrols as drugs with an antiarrhythmic activityInfo
- Publication number
- ZA773304B ZA773304B ZA00773304A ZA773304A ZA773304B ZA 773304 B ZA773304 B ZA 773304B ZA 00773304 A ZA00773304 A ZA 00773304A ZA 773304 A ZA773304 A ZA 773304A ZA 773304 B ZA773304 B ZA 773304B
- Authority
- ZA
- South Africa
- Prior art keywords
- aminoalkoxystyrols
- drugs
- aryl
- antiarrhythmic activity
- antiarrhythmic
- Prior art date
Links
- 230000003288 anthiarrhythmic effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762624918 DE2624918A1 (de) | 1976-06-03 | 1976-06-03 | Arzneimittel mit antiarrhythmischer wirkung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA773304B true ZA773304B (en) | 1979-02-28 |
Family
ID=5979714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA00773304A ZA773304B (en) | 1976-06-03 | 1977-06-02 | B-aryl-2-aminoalkoxystyrols as drugs with an antiarrhythmic activity |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4130650A (fr) |
| JP (1) | JPS52148627A (fr) |
| AU (1) | AU2574877A (fr) |
| BE (1) | BE855391A (fr) |
| DE (1) | DE2624918A1 (fr) |
| ZA (1) | ZA773304B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2818766A1 (de) | 1978-04-28 | 1979-11-08 | Basf Ag | 2-methyl-5-(2-hydroxystyryl)-1,3,4- thiadiazol |
| DE2818765A1 (de) * | 1978-04-28 | 1979-11-08 | Basf Ag | Aminoderivate des 2-methyl-5-(2-hydroxystyrol)-1,3,4-thiadiazols |
| DE2818999A1 (de) * | 1978-04-29 | 1979-11-15 | Basf Ag | Aminoderivate von 3-alkyl-5-(2- hydroxystyryl)-isoxazolen |
| DE2943405A1 (de) | 1979-10-26 | 1981-05-07 | Basf Ag, 6700 Ludwigshafen | Neue aminoderivate des 5-(2-hydroxystyryl)-isoxazols |
| DE2943406A1 (de) | 1979-10-26 | 1981-05-07 | Basf Ag, 6700 Ludwigshafen | Aminoderivate des 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazols |
| EP2877454B1 (fr) | 2012-07-18 | 2016-11-02 | University College Dublin National University Of Ireland, Dublin | Composés de 2-styryl-quinoléine antiangiogéniques |
-
1976
- 1976-06-03 DE DE19762624918 patent/DE2624918A1/de active Pending
-
1977
- 1977-05-25 US US05/800,309 patent/US4130650A/en not_active Expired - Lifetime
- 1977-06-02 JP JP6524677A patent/JPS52148627A/ja active Pending
- 1977-06-02 AU AU25748/77A patent/AU2574877A/en not_active Expired
- 1977-06-02 ZA ZA00773304A patent/ZA773304B/xx unknown
- 1977-06-03 BE BE178197A patent/BE855391A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2624918A1 (de) | 1977-12-15 |
| JPS52148627A (en) | 1977-12-10 |
| US4130650A (en) | 1978-12-19 |
| BE855391A (fr) | 1977-12-05 |
| AU2574877A (en) | 1978-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH13864A (en) | Untriakontapeptide with opiate activity | |
| JPS52124491A (en) | Surfaceesoaked catalysts | |
| JPS52114026A (en) | Pharmaceutical composition having antiiinflammation activity | |
| IL50217A0 (en) | Electrocatalyst | |
| GB1555723A (en) | N-acyl-substitued benzamides | |
| JPS5378598A (en) | Helicopter | |
| JPS5318614A (en) | Combined structure | |
| JPS54110532A (en) | Fenderrmirror structure | |
| GB1524653A (en) | Oxadiazoloyl-substituted compounds having pharmacological activity | |
| GB1551100A (en) | Drop-head support assembly | |
| JPS5310644A (en) | Minerallresin matrix | |
| JPS52124490A (en) | Hydrocarbonnconversion catalysts containing coooxidation accelerator | |
| IE45648L (en) | Biologically active gels | |
| JPS5356961A (en) | Cathode structure | |
| IE44836L (en) | Catalyst support | |
| JPS52128357A (en) | Antiitumor drug | |
| GB1549611A (en) | Hub assemblies | |
| JPS51123792A (en) | Stable ashhtitanite structure catalysts | |
| NZ184932A (en) | Dimeric indole-dihydroin-dolecarboxamides | |
| JPS52148627A (en) | Medicine having antiiarrhythmia active prorerty | |
| AU2320377A (en) | Electrode structure | |
| JPS5320410A (en) | Phytoquinoid with antitumor activity | |
| JPS5326791A (en) | Hydrocarbonnconversion catalysts | |
| JPS5386039A (en) | Pharmaceutical composition having antiitumor activity | |
| JPS5331316A (en) | Fireeproof structure |